This press release was originally distributed by SBWire. Albany, NY - ( SBWIRE ) - 20/02/2019 - Antiacne Prescription Medicines Market ...
This press release was originally distributed by SBWire.
Albany, NY - ( SBWIRE ) - 20/02/2019 - Antiacne Prescription Medicines Market
Acne is a common disease that leads to the formation of lesions or pimples. The disease is characterized by an overproduction of sebum due to the high production of male hormones, called androgens, during puberty. The overactivity of the hormone causes excessive sebum production. Sebum is a greasy substance that forms in the sebaceous gland, which is just below the skin surface. Sebum is generally considered a natural moisturizer for the skin. However, excessive sebum secretion causes pimples. Acne is characterized by the formation of nodules (large papules), comedones (blackheads and pimples), seborrhoea (red, scaly skin), scars and pimples.
View of the report
https://www.transparencymarketresearch.com/prescription-antiacne-drugs-market.html
Acne is a common problem in adolescents, with around 90% to 95% of adolescents and 83% and 85% of adolescents 16-17 years old having pimples. This disease dissolves in middle age. However, 20% of adolescents in adulthood can have persistent acne. According to various sources, it was estimated that about 650 million people had acne in 2010, and that acne was also the eighth most common disease in the world.
It is known that acne is caused by various factors such as hormonal factors, genetic factors, psychological factors, diet and infectious agents. Acne can not be permanently cured, but acne medications are available on the market and can prevent scarring. The drugs available for the treatment of acne include retinoids, antiandrogens, hormone treatments, benzoyl peroxide, antiseborrheic, keratolytic soaps, alpha-hydroxyl, salicylic acid and others.
Market for prescription drugs for acne: segmentation
The market for prescription medicines for acne can generally be classified according to the various medicines available on the market. Accutane (isotretinoin), Desquam-E (benzoyl peroxide), Cleocin T (clindamycin phosphate), benzamycin, topical erythromycin (A / T / S, erythrone, T-Stat), Retin-A (tretinoin) and Minocin (hydrochloride) Minocyclic)) There are several acne medications in the market. In addition to the above-mentioned medicines, tretinoin (Retin-A) is another popular acne medication available topically in the form of gel and cream. In addition, not all of the above medicines are prescription and can be used without a doctor's prescription without consultation with a physician. However, isotretinoin (Accutane) in capsule form is the only prescription drug. In addition, there are currently anti-acne combination medications such as BenzaClin, which combine clindamycin with benzoyl peroxide for the effective treatment of acne.
Request a brochure
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12266
Antiacne Prescription Market: Geographic Dynamics
The market for prescription medicines for acne can also be broken down geographically into North America, Europe, the Asia-Pacific region, and the rest of the world. Currently, North America holds the majority of anti-acne medicines on the world market. The dominance of this region has been observed due to the presence of a large number of pharmaceutical manufacturers, which means easy market penetration, high awareness of the population and an increase in the prevalence of acne. Recently, Ranbaxy Labs introduced Absorica (Isotretinoin) Capsules to the US market in 2012. This product is also a flagship brand in Ranbaxy's dermatology portfolio.
The Asia-Pacific region is expected to grow significantly in the future due to changes in diet and lifestyle habits, as well as greater patient awareness in the future. In addition, the growing penetration of pharmaceutical giants in the Asian region would also increase Asia's market share in the market for acne medicines. However, side effects associated with the use of acne medications are an important factor that could hinder the growth of this market.
Inquiry to the table of contents with tables and figures:
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=12266
Ranbaxy Laboratories, Roche Diagnostics, Johnson & Johnson and others are among the key players in this market.
The report provides a comprehensive assessment of the market. For this he has sound qualitative knowledge, historical data and verifiable projections of market size. The projections presented in the report are based on proven research methods and hypotheses. The research report serves as a benchmark for analysis and information on all aspects of the market, including regional markets, technologies, types and applications.
For more information about this release, visit the Web site : http://www.sbwire.com/press-releases/prescription-antiacne-drugs-market-trends-analysis-and-forecast-2016-2023-1153199 HTM
